1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Patient Monitoring Device Market Trends
  5. > Global Blood Glucose Monitoring (BGM) Devices Industry

Global Blood Glucose Monitoring (BGM) Devices Industry

  • February 2015
  • -
  • Global Industry Analysts
  • -
  • 358 pages

This report analyzes the worldwide markets for Blood Glucose Monitoring (BGM) Devices in US$ Million by the following Product Segments: Blood Glucose Strips, Blood Glucose Meters, and Lancets. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 83 companies including many key and niche players such as -

Abbott Diabetes Care, Inc.
AgaMatrix, Inc.
Arkray, Inc.
Bayer Healthcare
Bionime Corp.

Table Of Contents

Global Blood Glucose Monitoring (BGM) Devices Industry



I. INTRODUCTION, METHODOLOGY and PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation and Reporting Level I-2
Quantitative Techniques and Analytics I-3
Product Definitions and Scope of Study I-3
Blood Glucose Strips I-3
Blood Glucose Meters I-3
Lancets I-4


II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1
BGM Devices: Enabling Efficient Management of the Global
Diabetes Epidemic II-1
Table 1: Global Diabetes Mellitus Incidence among Ages 20-79
(2014E and 2035P): Prevalence (in Millions) and Percentage
Share by Geographic Region (includes corresponding
Graph/Chart) II-3

Table 2: Percentage Increase in DM Incidence among Ages 20-79
Worldwide by Geographic Region: 2013-2035 (includes
corresponding Graph/Chart) II-3

Table 3: Top Ten Countries Worldwide with the Highest Number
of People (in the Age Group 20-79 Years) with DM (in
Millions): 2014E and 2035P (includes corresponding Graph/Chart) II-4
Global Diabetes Prevalence: Few Alarming Facts II-5
Global Blood Glucose Monitoring (BGM) Market: Growth Drivers
in a Nut Shell II-5
Future Growth Driven by Product Innovations and Advancements II-6
Demand for BGM Products to Witness Varying Patterns in
Developed and Developing Markets II-6
Recession in Retrospect and the Road Ahead II-6

2. COMPETITION II-9
The Big Four in the Global BGM Devices Market II-9
Table 4: Leading Players in the Global Blood Glucose
Monitoring Devices Market (2014E): Percentage Market Share
Breakdown for Abbott, Bayer, LifeScan, Roche, and Others
(includes corresponding Graph/Chart) II-10
Select Blood Glucose Meters of Leading Manufacturers (2013):
Details of Company, Brand Name, Sample Size Required, Time
Taken (Seconds), and Special Features II-10
Competition with Local Pharma Companies Intensifies in
Regional Markets II-13
Quality Products at Low Prices: Mantra for Success in the
Marketplace II-13
Companies Cater to Local Needs to Garner Share in Regional
Markets II-13
Products Fail Revised ISO Accuracy Tolerance Requirements: A
Cause for Concern? II-14
Accuracy Tolerance Stipulation Changes to ISO 151971 in 2013
Over 2003 Version II-14

3. MARKET TRENDS, ISSUES AND DRIVERS II-15
Epidemic Nature of Global Diabetes Prevalence: A Strong Growth
Driver II-15
A “Silent Killer” in Both Developed as well as Developing
Nations II-15
Table 5: Prevalence of Diabetes Mellitus in North America
(2013 and 2035): Number of People with DM (in thousands) in
the 20-79 Age Group for the US, Canada and Mexico (includes
corresponding Graph/Chart) II-16

Table 6: Prevalence of Diabetes Mellitus in Europe (2013 and
2035): Number of People with DM (in thousands) in the 20-79
Age Group for 47 Countries in the Region II-17

Table 7: Prevalence of Diabetes Mellitus in South East Asia
(2013 and 2035): Number of People with DM (in thousands) in
the 20-79 Age Group for Bangladesh, Bhutan, India, Maldives,
Mauritius, Nepal, and Sri Lanka II-18

Table 8: Prevalence of Diabetes Mellitus in Western Asia,
Pacific Regions (2013 and 2035): Number of People with DM (in
thousands) in the 20-79 Age Group for 27 Countries in the
Region II-19

Table 9: Prevalence of Diabetes Mellitus in South and Central
America (2013 and 2035): Number of People with DM (in
thousands) in the 20-79 Age Group for 20 Countries in the
Region II-20

Table 10: Prevalence of Diabetes Mellitus in Africa (2013 and
2035): Number of People with DM (in thousands) in the 20-79
Age Group for 27 Countries in the Region II-21

Table 11: Prevalence of Diabetes Mellitus in Middle East and
North Africa (2013 and 2035): Number of People with DM (in
thousands) in the 20-79 Age Group for 19 Countries in the
Region II-22
Rising Incidence of Type 1 and Type 2 Diabetes in Children and
Young People II-22
Diabetes Prevalence Buoyed by Burgeoning Aging Populace II-23
Table 12: Global Population Statistics for the 65+ Age Group
(2013) (includes corresponding Graph/Chart) II-24

Table 13: Elderly Population (60+ Years) as a Percentage of
the Total Population (2012 and 2050) (includes corresponding
Graph/Chart) II-25

Table 14: Life Expectancy at Age 60 and 80 Years -
(2010-2015), (2020-2025) and (2045-2050) (includes
corresponding Graph/Chart) II-26

Table 15: Global Aging Population by Age Group: 1975-2050
(includes corresponding Graph/Chart) II-27

Table 16: Aging Population by Age Group in More Developed
Countries (1975-2050) (includes corresponding Graph/Chart) II-28

Table 17: Aging Population by Age Group in Less Developed
Countries (1975-2050) (includes corresponding Graph/Chart) II-29

Table 18: Aging Population by Age Group in Least Developed
Countries (1975-2050) (includes corresponding Graph/Chart) II-30
Targeted Screening of Aging Population Vital to Stem Diabetes
Epidemic II-30
Increasing Government Efforts for Better DM Management Bodes
Well for the Market II-31
Self-Monitoring of Blood Glucose (SMBG) Remains a Viable Option II-31
After PDAs, SMBG Makers Turn to Mobile Devices to Woo Users
on the Move II-32
Strong Smartphone Sales: A Major Opportunity Indicator for
Mobile-Based BGM Devices II-33
Table 19: Global Smartphones Sales in Million Units: 2011,
2013, 2015 and 2018 (includes corresponding Graph/Chart) II-33

Table 20: Smartphone Penetration Worldwide for Major
Countries (as a Percentage of Mobile Phone Users): 2014
(includes corresponding Graph/Chart) II-34

Table 21: Smartphone Penetration Worldwide (as a Percentage
of Total Population) for Major Countries: 2014E (includes
corresponding Graph/Chart) II-35
MySugr - Diabetic Management App with Gamification Approach II-35
Rising Significance of Remote Blood Glucose Monitoring Augurs
Well for Market Expansion II-36
Blood Glucose Test Strips: The Largest Segment II-37
FDA's New Guidelines for Test Strips II-37
Factors Affecting Meter Accuracies and its Impact on BGM II-38
New Surveillance Error Grid (SEG) for Monitoring Meter Accuracy II-38
Surging Incidence and Undiagnosed Population in Developing
Countries Offer Significant Growth Opportunities II-38
Table 22: Number of Undiagnosed Cases of Diabetes among
Adults in Age Group 20-80 Years by Geographic Region: 2014
(includes corresponding Graph/Chart) II-39
China: An Untapped Goldmine for Blood Glucose Monitoring Devices II-39
Rising Diabetic Populace Spurs Growth in the Indian BGM Market II-40

4. TECHNOLOGY INNOVATIONS and ADVANCEMENTS II-41
Artificial Pancreas Technology: A Potential Game Changer? II-42
Non-Invasive Devices: The Next Big Thing in Blood Glucose
Monitoring II-43
Major Non-Invasive Blood Glucose Monitoring Devices in
Research and Development: 2013 II-44
Select Companies' RandD Initiatives in Non-Invasive Glucose
Monitors (2013): Brief Description of Company, Technology,
Product, Site, and Key Features II-45
Diasensor 1000: The World's First Non-Invasive Glucose Sensor II-45
Earlobe Glucose Testing: A New Dimension to Non-Invasive
Glucose Monitoring II-45
Israeli Bioengineers Develop a New Non-Invasive Glucose
Monitoring Device II-46
Ultrasound Device to Monitor Glucose Levels II-46
Multi-Featured Blood Glucose Monitors II-46
Nanotechnology-based Breathalyzer for Glucose Monitoring II-47
Mobile Prescription Therapies - New Diabetes Management Solutions II-47
Dario by LabStyle - A Smartphone Compatible BGM Device II-47
Quick LLC to Develop iQuickIt Saliva Analyzer II-48
New Bluetooth-based Glucose Meters for Superior Connectivity II-48
Blood Glucose Test Strip Advancements Drive down Prices II-49
Test Strip Reimbursement Rates in Select Developed Nations: 2013 II-50
Real World Challenges Confront Non-Invasive and Painless BGM II-50

5. CONTINUOUS GLUCOSE MONITORING SYSTEMS: A MACRO PERSPECTIVE II-51
Continuous Glucose Monitoring (CGM) and Conventional Blood
Glucose Monitoring (BGM): Comparison of Key Parameters II-52
CGM Market Gradually Breaks through Barriers to Adoption II-53
Table 23: Penetration Rate (%) of CGM Devices in Type 1 and
Type 2 Diabetes Market in the United States: 2013 through
2020 (includes corresponding Graph/Chart) II-54
CGMS: Competitive Landscape II-54
Table 24: Leading Products/Brands in the Global Continuous
Glucose Monitoring Market (2013): Percentage Value Market
Share Breakdown for Dexcom G4 Platinum, Dexcom Seven Plus,
Free Style Navigator, Guardian Real Time, Minimed Paradigm
Revel and Others (includes corresponding Graph/Chart) II-55
Medtronic Dominates the Global CGM Devices Market II-55
Recent Noteworthy CGM Innovations of Medtronic II-56
Medtronic Introduces Medtronic Minimed Duo for Continuous
Glucose Monitoring II-56
Medtronic Develops Minimed 530G with Enlite II-56
CGM Companies Outsmart Each Other with Innovative Marketing
Offers II-57
Apple and Google Betting on Wearable Continuous Glucose Monitors II-57
Researchers at Glucovation to Develop Glucovation SugarSenz
CGM Sensor II-58
GlySens Focus on Developing Implantable Continuous Glucose
Monitor II-59
EyeSense to Develop Affordable CGM Device II-59
Becton, Dickinson to Develop an Insulin Pump with CGM Sensor II-60
Researchers Develop Prototype of Wearable Closed-Loop System II-60
Intensive Care Units: A Highly Promising Market for CGMs II-60
Key Challenges Hampering Widespread Adoption of CGM Systems II-60

6. DIABETES AND BGM DEVICES: OVERVIEW II-62
What is Diabetes? II-62
Types of Diabetes II-62
Type I Diabetes: Insulin-Dependent Diabetes Mellitus (IDDM) II-62
Type II Diabetes: Non-Insulin Dependent Diabetes Mellitus (
NIDDM) II-63
NIDDM: Higher Risk of Cardiovascular Disease II-64
Gestational Diabetes II-64
Impaired Fasting Glycaemia (IFG) and Impaired Glucose
Tolerance (IGT) II-64
Blood Glucose Monitoring II-64
Blood Glucose Monitoring Devices II-64
Blood Glucose Meters II-65
Blood Glucose Monitoring Meters: A Historical Perspective II-66
Types of Blood Glucose Meters II-66
All-In-One Blood Glucose Meters II-66
Combined Wrist Blood Pressure and Blood Glucose Meters II-66
Wrist-Watch Glucose Meters II-66
BGMs with In-Built Food Monitoring Feature II-67
Continuous Blood Glucose Meters II-67
Talking Blood Glucose Meters II-67
Painless Blood Glucose Meters II-67
Multisite Blood Glucose Meters II-67
Plasma Blood Glucose Meters II-68
Measurement Units II-68
Blood Glucose Strips II-68
Lancets II-68

7. PRODUCT INNOVATIONS/INTRODUCTIONS II-69
iHealth Introduces iHealth Align, World's Smallest Blood
Glucose Monitor II-69
Sanofi Introduces MyStar Extra®, a Self-Monitoring Blood
Glucose Meter II-69
Lifescan Unveils Onetouch Verio Blood Glucose Monitoring System II-69
Medtronic Unveils MiniMed® Duo in Europe II-69
Glooko Unveils MeterSync Blue Bluetooth Tool II-69
UniStrip Introduces GenStrip Generic Test Strip II-69
Omron Unveils Advanced Blood Glucose Monitors II-69
ARKRAY USA Announces Compatibility of GLUCOCARD® Blood Glucose
Meters with Glooko Mobile App II-70
Integrity Applications Displays GlucoTrack®Model DF-F Glucose
Monitoring Device II-70
Omron Introduces Two New Blood Glucose Monitors, HGM111 and
HGM112 II-70
Procaps Launches New GlucoQuickâ„¢ II-70
Bayer HealthCare Pharmaceuticals Unveils XT Glucometer and
NEXT Test strips under CONTOUR® Brand II-70
GE Healthcare and Bionime Introduce GE100 Blood Glucose
Monitoring System II-70
Nova Biomedical Unveils Nova Maxâ„¢ Blood Glucose Monitoring System II-70
BEURER Launches Three-in-one Blood Glucose Monitor II-71
Bayer Diabetes Care to Launch Glucometer II-71
Cambridge Consultants Design Eco-friendly Blood Glucose Monitor II-71
ARKRAY Unveils Audio-Enabled Blood Glucose Monitoring System II-71
Sanofi Introduces iBGStar iPhone Blood Glucose Meter in
Various Countries II-71
Abbott Introduces FreeStyle InsuLinx in Canada II-71
Eidia to Introduce LIFE CHECK II-71
Telcare Displays Cellular Blood Glucose Meter at AADE II-71

8. RECENT INDUSTRY ACTIVITY II-72
Medtronic Takes over Covidien II-72
Integrity Applications Inks Distribution Agreements for
GlucoTrack® Model DF-F II-72
Integrity Applications Inks Distribution Agreement for
GlucoTrack® Model DF-F with Felkasta JSC II-72
Integrity Applications Obtains CE Mark Approval for
GlucoTrack® DF-F II-72
Integrity Applications Signs Distribution Agreement for
GlucoTrack® Model DF-F in Turkey II-72
Integrity Applications Signs Distribution Agreement for
GlucoTrack® Model DF-F in New Zealand and Australia II-73
Philosys Receives FDA Approval for GMATE® SMART II-73
Abbott Obtains CE Mark for FreeStyle® Libre II-73
Integrity Applications Inks Manufacturing Agreement with Wistron II-73
Bionime Inks Subscription Agreement and Strategic Cooperation
Structure Agreement with Sannuo II-73
Dexcom Receives FDA Approval for Dexcom G4® PLATINUM Software II-73
Dexcom Receives FDA Approval for Dexcom SHAREâ„¢ II-73
Dexcom Receives FDA Approval for Dexcom G4® PLATINUM II-74
Nova StatStrip Glucose Hospital Meter System Obtains FDA
Clearance II-74
Animas Corporation Obtains FDA Approval for Animus Vibe
Insulin Pump II-74
Nipro Receives FDA Approval for TRUE METRIXâ„¢ and TRUE METRIXâ„¢ PRO II-74
Abbott Recalls FreeStyle Flash® BGM II-74
Abbott Recalls FreeStyle InsuLinx® BGMS II-74
LifeScan Initiates Recall and Replacement of OneTouch® Verio®
IQ BGMs II-74
Lifescan Obtains FDA Approval for OneTouch VerioSync II-74
Telcare BGM® Receives Clearance to Operate on Verizon Network II-75
LabStyle Innovations Inks with InnoMed to Distribute Darioâ„¢ II-75
Integrity Applications Obtains CE Mark Approval for
GlucoTrack® Model DF-F Glucose Monitoring Device II-75
Philosys Obtains FDA Approval for Gmate® VOICE BGM II-75
Abbott Obtains CE Mark for Ketone Monitoring Systemâ„¢ and
FreeStyle Optium Neo Blood Glucose II-75
Abbott Obtains FDA Approval for ß-Ketone Monitoring System™
and FreeStyle Precision Pro Blood Glucose II-75
ARKRAY Enters Partnership with Glooko II-75
Tandem Expands Development and Commercialization Agreement
with Dexcom II-76
GE Healthcare Signs Licensing Agreement with Bionime II-76
Modz Inks Agreement with Novo Nordisk II-76
Merck Serono Inks Distribution Deal with Mendor II-76
Abbott Renews Non-Exclusive Agreement with INSULET II-76
Pepex Biomedical Inks Manufacturing Agreement with Tech Group II-76
Pharmaco Bags Exclusive Distribution Rights for CareSens Blood
Glucose Meters II-76
Roche Obtains FDA Approval for ACCU-CHEK Inform II System II-76
Dexcom Obtains USFDA Approval and CE Mark for Dexcom G4â„¢
PLATINUM CGMS II-77
Abbott Obtains FDA Approval for FreeStyle InsuLinx BGM System II-77
StatStripâ„¢ Glucose Monitor from Nova Receives FDA Approval for
Neonatal Testing II-77
Philosys Obtains CE Mark for its Gmate® SMART BGMS II-77
Roche Obtains FDA Approval for Accu-Chek Combo System II-77

9. FOCUS ON SELECT GLOBAL PLAYERS II-78
Abbott Diabetes Care, Inc. (US) II-78
AgaMatrix, Inc. (US) II-78
Arkray, Inc. (Japan) II-78
Arkray USA, Inc. (US) II-79
Bayer Healthcare (US) II-79
Bionime Corp. (Taiwan) II-80
B. Braun Melsungen AG (Germany) II-80
DexCom, Inc. (US) II-81
LifeScan, Inc. (US) II-81
Medtronic (US) II-81
Nipro Diagnostics, Inc. (US) II-82
Nova Biomedical Corporation (US) II-82
Roche Diagnostics Corp. (US) II-83
Terumo Europe NV (Belgium) II-83

10. GLOBAL MARKET PERSPECTIVE II-84
Table 25: World Recent Past, Current and Future Analysis for
Blood Glucose Monitoring Devices by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin
America and Rest of World Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2014 through
2020 (includes corresponding Graph/Chart) II-84

Table 26: World Historic Review for Blood Glucose Monitoring
Devices by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America And Rest of
World Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2007 through 2013 (includes
corresponding Graph/Chart) II-85

Table 27: World 14-Year Perspective for Blood Glucose
Monitoring Devices by Geographic Region - Percentage Breakdown
of Revenue in Dollars for US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets for Years 2007, 2015 and 2020 (includes
corresponding Graph/Chart) II-86
Blood Glucose Monitoring Devices by Product Segment II-87
Table 28: World Recent Past, Current and Future Analysis for
Blood Glucose Strips by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2014 through 2020 (includes
corresponding Graph/Chart) II-87

Table 29: World Historic Review for Blood Glucose Strips by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) II-88

Table 30: World 14-Year Perspective for Blood Glucose Strips
by Geographic Region - Percentage Breakdown of Revenue in
Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Latin America and Rest of World Markets for Years
2007, 2015 and 2020 (includes corresponding Graph/Chart) II-89

Table 31: World Recent Past, Current and Future Analysis for
Blood Glucose Meters by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2014 through 2020 (includes
corresponding Graph/Chart) II-90

Table 32: World Historic Review for Blood Glucose Meters by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) II-91

Table 33: World 14-Year Perspective for Blood Glucose Meters
by Geographic Region - Percentage Breakdown of Revenue in
Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Latin America and Rest of World Markets for Years
2007, 2015 and 2020 (includes corresponding Graph/Chart) II-92

Table 34: World Recent Past, Current and Future Analysis for
Lancets by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2014 through 2020 (includes
corresponding Graph/Chart) II-93

Table 35: World Historic Review for Lancets by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Latin America and Rest of World Markets Independently
Analyzed with Annual Revenue Figures in US$ Million for Years
2007 through 2013 (includes corresponding Graph/Chart) II-94

Table 36: World 14-Year Perspective for Lancets by Geographic
Region - Percentage Breakdown of Revenue in Dollars for US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin
America and Rest of World Markets for Years 2007, 2015 and 2020
(includes corresponding Graph/Chart) II-95


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Current and Future Analysis III-1
Table 37: Leading 10 States in the US with the Highest Rate
(%) of Type 2 Diabetes: 2013 (includes corresponding
Graph/Chart) III-2

Table 38: Prevalence of Diabetes Mellitus in North America
(2013 and 2035): Number of People with DM (in thousands) in
the 20-79 Age Group for the US, Canada and Mexico (includes
corresponding Graph/Chart) III-3
Diabetes in America: Fast Facts III-3
Growth Drivers for BGM Devices Market in a Nut Shell III-4
Blood Glucose Monitoring Meters and Strips Sales Dip during
Recession III-5
Technologic Innovations Fuel US SMBG Market III-6
Accuracy: A Major Cause of Concern Plaguing BGM Systems III-6
Drugstores Benefit from the Diabetic Care Category III-6
Competitive Landscape III-7
Table 39: Leading Brands in the US Glucose Test Kits Market
(2013): Percentage Breakdown of Value Market Share for Accu
Chek Aviva Compact, Accu Chek Aviva Plus, Ascensia Contour,
Freestyle Lite, Lifescan One Touch Ultra, and Others
(includes corresponding Graph/Chart) III-7
Leading BGM Meters in the United States: Brief Description
of Manufacturer, Brand, Sample Size and Key Features III-7
Manufactures under Pressure to Reduce Prices of Strips III-12
Other Challenges Facing Market Participants III-12
Regulatory Scenario III-13
FDA's Proposal to Improve Blood Glucose Meter Accuracy in
Critical Care Units Gathers Criticism III-13
Regulations on Lancet Needles to be made More Stringent by FDA III-13
TGC Protocols: A Key Driver for Point of Care BGM Market III-13
Table 40: US Blood Glucose Strips Market (2014E):
Percentage Share Breakdown of Dollar Sales for SMBG Strips
and POC Glucose Strips (includes corresponding
Graph/Chart) III-14
Product Launches III-14
Strategic Corporate Developments III-15
Select Key Players III-19
B.Market Analytics III-23
Table 41: US Recent Past, Current and Future Analysis for
Blood Glucose Monitoring Devices by Product Segment - Blood
Glucose Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2014 through 2020 (includes corresponding
Graph/Chart) III-23

Table 42: US Historic Review for Blood Glucose Monitoring
Devices by Product Segment - Blood Glucose Strips, Blood
Glucose Meters and Lancets Markets Independently Analyzed
with Annual Revenue Figures in US$ Million for Years 2007
through 2013 (includes corresponding Graph/Chart) III-24

Table 43: US 14-Year Perspective for Blood Glucose
Monitoring Devices by Product Segment - Percentage Breakdown
of Revenue in Dollars for Blood Glucose Strips, Blood
Glucose Meters and Lancets Markets for Years 2007, 2015 and
2020 (includes corresponding Graph/Chart) III-25

2. CANADA III-26
A.Market Analysis III-26
Current and Future Analysis III-26
Product Launch III-26
B.Market Analytics III-27
Table 44: Canadian Recent Past, Current and Future Analysis
for Blood Glucose Monitoring Devices by Product Segment -
Blood Glucose Strips, Blood Glucose Meters and Lancets
Markets Independently Analyzed with Annual Revenue Figures
in US$ Million for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-27

Table 45: Canadian Historic Review for Blood Glucose
Monitoring Devices by Product Segment - Blood Glucose
Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-28

Table 46: Canadian 14-Year Perspective for Blood Glucose
Monitoring Devices by Product Segment - Percentage Breakdown
of Revenue in Dollars for Blood Glucose Strips, Blood
Glucose Meters and Lancets Markets for Years 2007, 2015 and
2020 (includes corresponding Graph/Chart) III-29

3. JAPAN III-30
A.Market Analysis III-30
Current and Future Analysis III-30
Japan: A Leading Medical Device Exporting Nation III-30
Product Launch III-31
Arkray, Inc. - A Key Japanese Player III-31
B.Market Analytics III-32
Table 47: Japanese Recent Past, Current and Future Analysis
for Blood Glucose Monitoring Devices by Product Segment -
Blood Glucose Strips, Blood Glucose Meters and Lancets
Markets Independently Analyzed with Annual Revenue Figures
in US$ Million for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-32

Table 48: Japanese Historic Review for Blood Glucose
Monitoring Devices by Product Segment - Blood Glucose
Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-33

Table 49: Japanese 14-Year Perspective for Blood Glucose
Monitoring Devices by Product Segment - Percentage Breakdown
of Revenue in Dollars for Blood Glucose Strips, Blood
Glucose Meters and Lancets Markets for Years 2007, 2015 and
2020 (includes corresponding Graph/Chart) III-34

4. EUROPE III-35
A.Market Analysis III-35
Current and Future Scenario III-35
Prevalence of Diabetes in Europe: Aging Population Dominate III-35
Table 50: Prevalence of Diabetes Mellitus in Europe (2013 and
2035): Number of People with DM (in thousands) in the 20-79
Age Group for 47 Countries in the Region III-36
Obesity: A Major Cause of Diabetes in Europe III-37
Diabetes Care in Europe Riddled with Challenges III-37
St. Vincent Declaration: A Step in the Right Direction III-38
B.Market Analytics III-40
Table 51: European Recent Past, Current and Future Analysis
for Blood Glucose Monitoring Devices by Geographic Region -
France, Germany, UK, Italy, Spain, Russia and Rest of Europe
Markets Independently Analyzed with Annual Revenue Figures
in US$ Million for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-40

Table 52: European Historic Review for Blood Glucose
Monitoring Devices by Geographic Region - France, Germany,
UK, Italy, Spain, Russia and Rest of Europe Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-41

Table 53: European 14-Year Perspective for Blood Glucose
Monitoring Devices by Geographic Region - Percentage
Breakdown of Revenue in Dollars for France, Germany, UK,
Italy, Spain, Russia and Rest of Europe Markets for Years
2007, 2015 and 2020 (includes corresponding Graph/Chart) III-42

Table 54: European Recent Past, Current and Future Analysis
for Blood Glucose Monitoring Devices by Product Segment -
Blood Glucose Strips, Blood Glucose Meters and Lancets
Markets Independently Analyzed with Annual Revenue Figures
in US$ Million for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-43

Table 55: European Historic Review for Blood Glucose
Monitoring Devices by Product Segment - Blood Glucose
Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-44

Table 56: European 14-Year Perspective for Blood Glucose
Monitoring Devices by Product Segment - Percentage Breakdown
of Revenue in Dollars for Blood Glucose Strips, Blood
Glucose Meters and Lancets Markets for Years 2007, 2015 and
2020 (includes corresponding Graph/Chart) III-45

4a. FRANCE III-46
A.Market Analysis III-46
Current and Future Analysis III-46
B.Market Analytics III-46
Table 57: French Recent Past, Current and Future Analysis for
Blood Glucose Monitoring Devices by Product Segment - Blood
Glucose Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2014 through 2020 (includes corresponding
Graph/Chart) III-46

Table 58: French Historic Review for Blood Glucose
Monitoring Devices by Product Segment - Blood Glucose
Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-47

Table 59: French 14-Year Perspective for Blood Glucose
Monitoring Devices by Product Segment - Percentage Breakdown
of Revenue in Dollars for Blood Glucose Strips, Blood
Glucose Meters and Lancets Markets for Years 2007, 2015 and
2020 (includes corresponding Graph/Chart) III-48

4b. GERMANY III-49
A.Market Analysis III-49
Current and Future Analysis III-49
Product Launch III-49
B. Braun Melsungen Ag - A Key German Player III-49
B.Market Analytics III-50
Table 60: German Recent Past, Current and Future Analysis for
Blood Glucose Monitoring Devices by Product Segment - Blood
Glucose Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2014 through 2020 (includes corresponding
Graph/Chart) III-50

Table 61: German Historic Review for Blood Glucose
Monitoring Devices by Product Segment - Blood Glucose
Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-51

Table 62: German 14-Year Perspective for Blood Glucose
Monitoring Devices by Product Segment - Percentage Breakdown
of Revenue in Dollars for Blood Glucose Strips, Blood
Glucose Meters and Lancets Markets for Years 2007, 2015 and
2020 (includes corresponding Graph/Chart) III-52

4c. ITALY III-53
A.Market Analysis III-53
Current and Future Analysis III-53
B.Market Analytics III-53
Table 63: Italian Recent Past, Current and Future Analysis for
Blood Glucose Monitoring Devices by Product Segment - Blood
Glucose Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2014 through 2020 (includes corresponding
Graph/Chart) III-53

Table 64: Italian Historic Review for Blood Glucose
Monitoring Devices by Product Segment - Blood Glucose
Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-54

Table 65: Italian 14-Year Perspective for Blood Glucose
Monitoring Devices by Product Segment - Percentage Breakdown
of Revenue in Dollars for Blood Glucose Strips, Blood
Glucose Meters and Lancets Markets for Years 2007, 2015 and
2020 (includes corresponding Graph/Chart) III-55

4d. THE UNITED KINGDOM III-56
A.Market Analysis III-56
Current and Future Analysis III-56
Self-Monitoring Blood Glucose Meters Gain Popularity III-56
Five Smallest Blood Glucose Meters in the UK: Brief Description III-56
Product Launches III-57
B.Market Analytics III-58
Table 66: UK Recent Past, Current and Future Analysis for
Blood Glucose Monitoring Devices by Product Segment - Blood
Glucose Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2014 through 2020 (includes corresponding
Graph/Chart) III-58

Table 67: UK Historic Review for Blood Glucose Monitoring
Devices by Product Segment - Blood Glucose Strips, Blood
Glucose Meters and Lancets Markets Independently Analyzed
with Annual Revenue Figures in US$ Million for Years 2007
through 2013 (includes corresponding Graph/Chart) III-59

Table 68: UK 14-Year Perspective for Blood Glucose
Monitoring Devices by Product Segment - Percentage Breakdown
of Revenue in Dollars for Blood Glucose Strips, Blood
Glucose Meters and Lancets Markets for Years 2007, 2015 and
2020 (includes corresponding Graph/Chart) III-60

4e. SPAIN III-61
A.Market Analysis III-61
Current and Future Analysis III-61
B.Market Analytics III-61
Table 69: Spanish Recent Past, Current and Future Analysis for
Blood Glucose Monitoring Devices by Product Segment - Blood
Glucose Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2014 through 2020 (includes corresponding
Graph/Chart) III-61

Table 70: Spanish Historic Review for Blood Glucose
Monitoring Devices by Product Segment - Blood Glucose
Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-62

Table 71: Spanish 14-Year Perspective for Blood Glucose
Monitoring Devices by Product Segment - Percentage Breakdown
of Revenue in Dollars for Blood Glucose Strips, Blood
Glucose Meters and Lancets Markets for Years 2007, 2015 and
2020 (includes corresponding Graph/Chart) III-63

4f. RUSSIA III-64
A.Market Analysis III-64
Current and Future Analysis III-64
B.Market Analytics III-64
Table 72: Russian Recent Past, Current and Future Analysis for
Blood Glucose Monitoring Devices by Product Segment - Blood
Glucose Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2014 through 2020 (includes corresponding
Graph/Chart) III-64

Table 73: Russian Historic Review for Blood Glucose
Monitoring Devices by Product Segment - Blood Glucose
Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-65

Table 74: Russian 14-Year Perspective for Blood Glucose
Monitoring Devices by Product Segment - Percentage Breakdown
of Revenue in Dollars for Blood Glucose Strips, Blood
Glucose Meters and Lancets Markets for Years 2007, 2015 and
2020 (includes corresponding Graph/Chart) III-66

4g. REST OF EUROPE III-67
A.Market Analysis III-67
Current and Future Analysis III-67
Product Launch III-67
Strategic Corporate Developments III-67
Terumo Europe Nv - A Key Player III-68
B.Market Analytics III-70
Table 75: Rest of Europe Recent Past, Current and Future
Analysis for Blood Glucose Monitoring Devices by Product
Segment - Blood Glucose Strips, Blood Glucose Meters and
Lancets Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-70

Table 76: Rest of Europe Historic Review for Blood Glucose
Monitoring Devices by Product Segment - Blood Glucose
Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-71

Table 77: Rest of Europe 14-Year Perspective for Blood
Glucose Monitoring Devices by Product Segment - Percentage
Breakdown of Revenue in Dollars for Blood Glucose Strips,
Blood Glucose Meters and Lancets Markets for Years 2007,
2015 and 2020 (includes corresponding Graph/Chart) III-72

5. ASIA-PACIFIC III-73
A.Market Analysis III-73
Current and Future Analysis III-73
Rising Diabetes Incidence in Asia-Pacific Offers Significant
Growth Opportunities III-73
Table 78: Prevalence of Diabetes Mellitus in South East
Asia (2013 and 2035): Number of People with DM (in thousands)
in the 20-79 Age Group for Bangladesh, Bhutan, India,
Maldives, Mauritius, Nepal, and Sri Lanka III-74

Table 79: Prevalence of Diabetes Mellitus in Western
Asia-Pacific Regions (2013 and 2035): Number of People with
DM (in thousands) in the 20-79 Age Group for 27 Countries
in the Region III-74
High Growth on Cards for SMBG Devices III-75
Asia Suffers from Lack of Focus on Diabetes Care III-75
Healthcare Societies and Associations Spread Awareness of
Diabetes III-76
Western Pacific Declaration on Diabetes III-76
Competitive Landscape III-76
Distribution Scenario III-77
B.Market Analytics III-77
Table 80: Asia-Pacific Recent Past, Current and Future
Analysis for Blood Glucose Monitoring Devices by Geographic
Region - China, India, and Rest of Asia-Pacific Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2014 through 2020 (includes corresponding
Graph/Chart) III-77

Table 81: Asia-Pacific Historic Review for Blood Glucose
Monitoring Devices by Geographic Region - China, India, and
Rest of Asia-Pacific Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2007 through
2013 (includes corresponding Graph/Chart) III-78

Table 82: Asia-Pacific 14-Year Perspective for Blood Glucose
Monitoring Devices by Geographic Region - Percentage
Breakdown of Revenue in Dollars for China, India, and Rest
of Asia-Pacific Markets for Years 2007, 2015 and 2020
(includes corresponding Graph/Chart) III-79

Table 83: Asia-Pacific Recent Past, Current and Future
Analysis for Blood Glucose Monitoring Devices by Product
Segment - Blood Glucose Strips, Blood Glucose Meters and
Lancets Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-80

Table 84: Asia-Pacific Historic Review for Blood Glucose
Monitoring Devices by Product Segment - Blood Glucose
Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-81

Table 85: Asia-Pacific 14-Year Perspective for Blood Glucose
Monitoring Devices by Product Segment - Percentage Breakdown
of Revenue in Dollars for Blood Glucose Strips, Blood
Glucose Meters and Lancets Markets for Years 2007, 2015 and
2020 (includes corresponding Graph/Chart) III-82

5a. CHINA III-83
A.Market Analysis III-83
Current and Future Analysis III-83
China: A Market with Huge Untapped Potential for BGM Devices III-83
Competitive Landscape III-83
B.Market Analytics III-84
Table 86: Chinese Recent Past, Current and Future Analysis for
Blood Glucose Monitoring Devices by Product Segment - Blood
Glucose Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2014 through 2020 (includes corresponding
Graph/Chart) III-84

Table 87: Chinese Historic Review for Blood Glucose
Monitoring Devices by Product Segment - Blood Glucose
Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-85

Table 88: Chinese 14-Year Perspective for Blood Glucose
Monitoring Devices by Product Segment - Percentage Breakdown
of Revenue in Dollars for Blood Glucose Strips, Blood
Glucose Meters and Lancets Markets for Years 2007, 2015 and
2020 (includes corresponding Graph/Chart) III-86

5b. INDIA III-87
A.Market Analysis III-87
Outlook III-87
Diabetic Epidemic in the Country Spurs Market Growth III-87
Market Restraints III-88
Competitive Landscape III-88
Product Launches III-89
B.Market Analytics III-90
Table 89: Indian Recent Past, Current and Future Analysis for
Blood Glucose Monitoring Devices by Product Segment - Blood
Glucose Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2014 through 2020 (includes corresponding
Graph/Chart) III-90

Table 90: Indian Historic Review for Blood Glucose
Monitoring Devices by Product Segment - Blood Glucose
Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-91

Table 91: Indian 14-Year Perspective for Blood Glucose
Monitoring Devices by Product Segment - Percentage Breakdown
of Revenue in Dollars for Blood Glucose Strips, Blood
Glucose Meters and Lancets Markets for Years 2007, 2015 and
2020 (includes corresponding Graph/Chart) III-92

5c. REST OF ASIA-PACIFIC III-93
A.Market Analysis III-93
Current and Future Analysis III-93
A Review Of Select Markets III-93
Australia: A Growing Market for Blood Glucose Monitoring
Devices III-93
Hong Kong: Low Awareness Levels Offer Opportunities III-93
Malaysia Witness Surge in Chronic Diseases Incidence,
including DM III-94
Taiwan: SMBG Devices Market on the Rise III-94
Strategic Corporate Developments III-94
Select Key Players III-95
B.Market Analytics III-97
Table 92: Rest of Asia-Pacific Recent Past, Current and Future
Analysis for Blood Glucose Monitoring Devices by Product
Segment - Blood Glucose Strips, Blood Glucose Meters and
Lancets Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-97

Table 93: Rest of Asia-Pacific Historic Review for Blood
Glucose Monitoring Devices by Product Segment - Blood
Glucose Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-98

Table 94: Rest of Asia-Pacific 14-Year Perspective for Blood
Glucose Monitoring Devices by Product Segment - Percentage
Breakdown of Revenue in Dollars for Blood Glucose Strips,
Blood Glucose Meters and Lancets Markets for Years 2007,
2015 and 2020 (includes corresponding Graph/Chart) III-99

6. LATIN AMERICA III-100
A.Market Analysis III-100
Current and Future Analysis III-100
Table 95: Prevalence of Diabetes Mellitus in South and
Central America (2013 and 2035): Number of People with DM (in
thousands) in the 20-79 Age Group for 20 Countries in the
Region III-100
National Diabetes Programs III-101
Product Launch III-101
B.Market Analytics III-102
Table 96: Latin American Recent Past, Current and Future
Analysis for Blood Glucose Monitoring Devices by Product
Segment - Blood Glucose Strips, Blood Glucose Meters and
Lancets Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-102

Table 97: Latin American Historic Review for Blood Glucose
Monitoring Devices by Product Segment - Blood Glucose
Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-103

Table 98: Latin American 14-Year Perspective for Blood
Glucose Monitoring Devices by Product Segment - Percentage
Breakdown of Revenue in Dollars for Blood Glucose Strips,
Blood Glucose Meters and Lancets Markets for Years 2007,
2015 and 2020 (includes corresponding Graph/Chart) III-104

7. REST OF WORLD III-105
A.Market Analysis III-105
Current and Future Analysis III-105
United Arab Emirates: Rising Diabetic Cases to Propel Market
Demand III-105
Key Statistics: Diabetes Prevalence in Middle East and
African Regions III-105
Table 99: Prevalence of Diabetes Mellitus in Africa (2013 and
2035): Number of People with DM (in thousands) in the 20-79
Age Group for 27 Countries in the Region III-105

Table 100: Prevalence of Diabetes Mellitus in Middle East and
North Africa (2013 and 2035): Number of People with DM (in
thousands) in the 20-79 Age Group for 19 Countries in the
Region III-106
Product Launch III-107
Strategic Corporate Developments III-107
B.Market Analytics III-108
Table 101: Rest of World Recent Past, Current and Future
Analysis for Blood Glucose Monitoring Devices by Product
Segment - Blood Glucose Strips, Blood Glucose Meters and
Lancets Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-108

Table 102: Rest of World Historic Review for Blood Glucose
Monitoring Devices by Product Segment - Blood Glucose
Strips, Blood Glucose Meters and Lancets Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) III-109

Table 103: Rest of World 14-Year Perspective for Blood
Glucose Monitoring Devices by Product Segment - Percentage
Breakdown of

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Europe Market Report for Fundus Cameras 2017 - MedCore

Europe Market Report for Fundus Cameras 2017 - MedCore

  • $ 6495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description General Report Contents - Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends - Market Drivers & Limiters for each chapter segment - Competitive Analysis for each chapte ...

Asia-Pacific Neonatal Monitors Market Outlook to 2022

Asia-Pacific Neonatal Monitors Market Outlook to 2022

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Asia-Pacific Neonatal Monitors Market Outlook to 2022 Summary GlobalData’s new report, "Asia-Pacific Neonatal Monitors Market Outlook to 2022", provides key market data on the Asia-Pacific Neonatal Monitors ...

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-El ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.